BMY — Bristol-Myers Squibb Co Share News
0.000.00%
Last trade - 00:00- $110.27bn
- $144.28bn
- $48.19bn
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Danaher, Brinker International
U.S. STOCKS ON THE MOVE-Texas Instruments, Seagate, Nextpower
U.S. drugmakers slip as 2028 Medicare price list adds 15 medicines
U.S. RESEARCH ROUNDUP- Boeing, Carvana, UnitedHealth
Brief: CMS Announces Selection Of Drugs For Third Cycle Of The Medicare Drug Price Negotiation Program
Indian drugmaker Cipla falls on JPM downgrade to "neutral"
Janux Therapeutics, Bristol Myers enter up to $850 million deal to develop cancer drug
Janux shares rise on global cancer drug deal with Bristol Myers
Preview: Analysts expect Dr Reddy's to post first profit drop in five quarters
Bristol Myers partners with Microsoft for AI-driven lung cancer detection
Brief: Bristol Myers Squibb Announces Collaboration With Microsoft To Advance Ai-Driven Early Detection Of Lung Cancer
Factbox: Major deals involving U.S. drugmakers and biotechs over the past decade
U.S. RESEARCH ROUNDUP-Cencora, Kennametal, Regeneron Pharmaceuticals
U.S. RESEARCH ROUNDUP-Ardelyx, RPM International, Trubridge
Biopharma firm Alumis rises after boosted $300 mln stock sale
Trump administration cannot proceed with pilot drug rebate program, US court rules (updated)
Trump administration cannot proceed with pilot drug rebate program, US court rules
Biopharma firm Alumis extends gains after commencing $175 mln stock offering
Alumis' skin disease drug meets main goal in late-stage trials; shares surge (updated)